Autoimmune thyroid diseases (AITD), mainly Hashimoto’s thyroiditis (HT) and Graves’ disease (GD), are a consequence of loss of immune tolerance toward organ-specific self-antigens, including thyroglobulin (TG), thyroperoxidase (TPO), and the receptor for TSH1. Here, TPO is linked to hematocrit.